Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

Published Date: 22 Mar 2024

Patients with a particular allele of the HSD3B1 gene have a mortality rate specific to cancer that is twice as high.

Read Full News

Latest News

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Latest News

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

News All Time

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

However, rates were improved from previous survey results

FDA Says First 'Real-Time' Clinical Trial Is Underway

Two sponsors are on board, with a larger pilot program planned later this year

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

Mim8 prophylaxis significantly reduced bleeding events in patients with or without inhibitors

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

Three-fourths of patients had cancer-free mediastinal lymph nodes, clear surgical margins in 93%

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

Disease-free survival of 96% with no severe GVHD in acute leukemia, other blood cancers

FDA Panel Endorses Capivasertib Use in Prostate Cancer

Agency staff expressed uncertainty over whether PFS benefit was "clinically meaningful"

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

News, features, and commentary about cancer-related issues

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

His death followed a hospitalization for cancer treatment side effects

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

Here's what two brain surgeries taught me about public health and care access

Woman Loses 6-Year Battle With Mouth Tumor

Rare ameloblastoma rapidly recurs and metastasizes despite numerous radical excisions

Why Did Rare Cancer Shrink on Its Own?

Case illustrates the mystery of spontaneous regression

Oncologist on Hantavirus Cruise; Bile Duct Cancer Drug OK'd; Untreated Lung Cancers

News, features, and commentary about cancer-related issues

What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?

The cause lies in a lengthy history of cancer treatment, confirmed by histopathology analysis

What Do Patients Want Doctors to Know About Breast Cancer Recurrence?

What Do Patients Want Doctors to Know About Breast Cancer Recurrence?

Babies Are Bleeding to Death as Parents Reject a Vitamin Shot Given at Birth

Deaths directly attributed to vitamin K deficiency bleeding have started to climb in recent years

How Doctors Can Thrive in a World of Constant Interruption

A steady deluge of interruptions, demands, and distractions drain physicians and raise the risk of errors. Here’s how to protect your focus.

Recommended News For You

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.

Prostate cancer screening program beneficial in top decile of polygenic risk score

As compared to proton therapy, proton therapy is very effective in treating esophageal cancer.

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.

New policy review highlights the importance of health-related quality of life in advanced cancer

Recommended Articles For You

Hemoglobin C: Understanding its Role in Sickle Cell Disease 

The Benefits of Understanding Haptoglobin High: What You Need to Know 

Cold Antibody AIHA and Neoplastic Disorders: Unraveling the Clinical and Pathogenic Link 

Demystifying Hematoma Rectus Sheath: Knowing the Symptoms and Causes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.

2.

The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.

3.

Woman Loses 6-Year Battle With Mouth Tumor

4.

Shorter but More Intense RT: A Better Option for HNSCC?

5.

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

1.

The Science Behind Thrombolytic Drugs and Their Benefits 

2.

Unlocking the Mystery of Elliptocytes: Exploring the Unusual Shape of Red Blood Cells

3.

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps

4.

Unlocking the Potential of Cancer Antigen 19-9 for Early Detection

5.

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII

2.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot